Your browser doesn't support javascript.
loading
Expamers: a new technology to control T cell activation.
Poltorak, Mateusz P; Graef, Patricia; Tschulik, Claudia; Wagner, Michaela; Cletiu, Vlad; Dreher, Stefan; Borjan, Bojana; Fraessle, Simon P; Effenberger, Manuel; Turk, Martin; Busch, Dirk H; Plitzko, Juergen; Kugler, David G; Ragan, Seamus; Schmidt, Thomas; Stemberger, Christian; Germeroth, Lothar.
Afiliación
  • Poltorak MP; Juno Therapeutics GmbH, a Bristol-Myers Squibb Company, Grillparzerstr. 10, 81675, Munich, Germany. mateusz.poltorak@bms.com.
  • Graef P; Juno Therapeutics GmbH, a Bristol-Myers Squibb Company, Grillparzerstr. 10, 81675, Munich, Germany.
  • Tschulik C; Juno Therapeutics GmbH, a Bristol-Myers Squibb Company, Grillparzerstr. 10, 81675, Munich, Germany.
  • Wagner M; Juno Therapeutics GmbH, a Bristol-Myers Squibb Company, Grillparzerstr. 10, 81675, Munich, Germany.
  • Cletiu V; Juno Therapeutics GmbH, a Bristol-Myers Squibb Company, Grillparzerstr. 10, 81675, Munich, Germany.
  • Dreher S; Juno Therapeutics GmbH, a Bristol-Myers Squibb Company, Grillparzerstr. 10, 81675, Munich, Germany.
  • Borjan B; Juno Therapeutics GmbH, a Bristol-Myers Squibb Company, Grillparzerstr. 10, 81675, Munich, Germany.
  • Fraessle SP; Juno Therapeutics GmbH, a Bristol-Myers Squibb Company, Grillparzerstr. 10, 81675, Munich, Germany.
  • Effenberger M; Institute for Medical Microbiology Immunology and Hygiene, Technical University of Munich, Munich, Germany.
  • Turk M; Juno Therapeutics GmbH, a Bristol-Myers Squibb Company, Grillparzerstr. 10, 81675, Munich, Germany.
  • Busch DH; Institute for Medical Microbiology Immunology and Hygiene, Technical University of Munich, Munich, Germany.
  • Plitzko J; Max Planck Institute of Biochemistry, Am Klopferspitz 18, 82152, Martinsried, Germany.
  • Kugler DG; Institute for Medical Microbiology Immunology and Hygiene, Technical University of Munich, Munich, Germany.
  • Ragan S; Max Planck Institute of Biochemistry, Am Klopferspitz 18, 82152, Martinsried, Germany.
  • Schmidt T; Juno Therapeutics Inc., a Bristol-Myers Squibb Company, 400 Dexter Avenue North, Suite 1200, Seattle, WA, 98109, USA.
  • Stemberger C; Juno Therapeutics Inc., a Bristol-Myers Squibb Company, 400 Dexter Avenue North, Suite 1200, Seattle, WA, 98109, USA.
  • Germeroth L; Juno Therapeutics GmbH, a Bristol-Myers Squibb Company, Grillparzerstr. 10, 81675, Munich, Germany.
Sci Rep ; 10(1): 17832, 2020 10 20.
Article en En | MEDLINE | ID: mdl-33082362
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Activación de Linfocitos / Linfocitos T / Indicadores y Reactivos Límite: Animals / Humans Idioma: En Revista: Sci Rep Año: 2020 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Activación de Linfocitos / Linfocitos T / Indicadores y Reactivos Límite: Animals / Humans Idioma: En Revista: Sci Rep Año: 2020 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido